Overview

Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
To assess the effect of prophylactic antiglaucoma agents in prevention of acute intraocular pressure rise after intravitreal injection.
Phase:
N/A
Details
Lead Sponsor:
Mashhad University of Medical Sciences
Treatments:
Acetazolamide
Bevacizumab
Brimonidine Tartrate
Mannitol
Timolol